Radiotherapy innovation in rare diseases-focusing on the value of single institutional experiences for hypofractionated radiotherapy in soft tissue sarcoma

Radiother Oncol. 2023 Jun:183:109626. doi: 10.1016/j.radonc.2023.109626. Epub 2023 Mar 22.

Authors

Zachary S Mayo¹, Nathan Mesko², Lukas Nystrom², Chirag S Shah¹, Jacob G Scott¹, Shauna R Campbell³

Affiliations

¹ Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH, United States.
² Department of Orthopaedic Surgery, Cleveland Clinic, Cleveland, OH, United States.
³ Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH, United States. Electronic address: campbes6@ccf.org.

PMID: 36963441
DOI: 10.1016/j.radonc.2023.109626

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Radiation Dose Hypofractionation
Rare Diseases
Sarcoma* / radiotherapy
Soft Tissue Neoplasms*